Literature research of Crohn’s disease in Chinese journals from 1978 to 2017_West China Medical Journal

Authors：

ZHU Min , WANG Zhujun , MU Jingxi , CHEN Yiding , ZENG Zhen , OUYANG Qin ,  ZHANG Hu

Department of Gastroenterology & Center of Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding author：

ZHANG Hu, Email: zhanghu@scu.edu.cn

Keywords：

Crohn’s disease; SinoMed database; Literature research; Evidence-based article; Research institution

DOI：

10.7507/1002-0179.201908037

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the current research status and its developing trend of Crohn’s disease (CD) in Chinese journals in the past 40 years, and to provide reference for future research on CD.Methods With “Crohn’s disease” as the retrieval word, the literature about CD published from January 1978 to December 2017 were retrieved in the SinoMed database. The distributions of publication dates, journals, research institutions, and regions of literature were analyzed by EndNote, Excel, MySQL, and GraphPad Prism softwares.Results A total of 2 140 papers matched the searching criteria, including 1 391 papers published in the core journals. The number of papers increased by year, especially in the past 20 years, the growth rate of the total number of papers every 5 years was 96.67%, 202.54%, 85.15%, and 29.35%, respectively. A total of 152 papers met the criteria of evidence-based documents, and the proportion of evidence-based articles in the total papers every 5 years was 2.54%, 3.92%, 4.69%, and 12.16%, respectively. In the respect of region distribution of literature, the first addresses of 1 060 papers were in East China, accounting for 50.36% of the total number of papers. Jiangsu Province, Guangdong Province, Shanghai, Zhejiang Province, and Beijing had published a total of 1 257 papers, accounting for 59.71% of the total number of papers. In our research field, most of the studies were conducted by teaching hospitals.Conclusions In the past 40 years, the output of research on CD increased significantly in China. The proportion of evidence-based articles has increased, while the number of evidence-based research still needs to be improved. The regional distribution of literature was unbalanced, and teaching hospitals played a vital role in the research field.

Citation： ZHU Min, WANG Zhujun, MU Jingxi, CHEN Yiding, ZENG Zhen, OUYANG Qin, ZHANG Hu. Literature research of Crohn’s disease in Chinese journals from 1978 to 2017. West China Medical Journal, 2020, 35(1): 60-66. doi: 10.7507/1002-0179.201908037 Copy

1.	中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见 (2012 年·广州). 胃肠病学, 2012, 17(12): 763-781.
2.	Torres J, Mehandru S, Colombel JF, et al. Crohn’s disease. Lancet, 2017, 389(10080): 1741-1755.
3.	Nishida A, Inoue R, Inatomi O, et al. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol, 2018, 11(1): 1-10.
4.	Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc, 2019, 94(1): 155-165.
5.	Thia KT, Sandborn WJ, Harmsen WS, et al. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology, 2010, 139(4): 1147-1155.
6.	Lee DW, Koo JS, Choe JW, et al. Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery. World J Gastroenterol, 2017, 23(35): 6474-6481.
7.	Coward S, Clement F, Benchimol EI, et al. Past and future burden of inflammatory bowel diseases based on modeling of population-based data. Gastroenterology, 2019, 156(5): 1345-1353.
8.	Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet, 2018, 390(1114): 2769-2778.
9.	Wang YF, Ouyang Q, Hu RW. Progression of inflammatory bowel disease in China. J Dig Dis, 2010, 11(2): 76-82.
10.	Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn’s and Colitis Epidemiology Study. Gastroenterology, 2013, 145(1): 158-165.
11.	钱家鸣, 杨红. 中国炎症性肠病研究的历史回顾、现状和展望. 中国实用内科杂志, 2015, 35(9): 727-730.
12.	Kaplan GG, Ng SC. Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China. Lancet Gastroenterol Hepatol, 2016, 1(4): 307-316.
13.	APDW 2004 Chinese IBD Working Group. Retrospective analysis of 515 cases of Crohn’s disease hospitalization in China: nationwide study from 1990 to 2003. J Gastroenterol Hepatol, 2006, 21(6): 1009-1015.
14.	Chen X, Yang K, Xu Y, et al. Top-100 highest-cited original articles in inflammatory bowel disease: a bibliometric analysis. Medicine, 2019, 98(20): e15718.
15.	郑家驹, 史肖华, 竺霞霜, 等. 我国克罗恩病不同年代发病率及患病率的比较. 中华内科杂志, 2011, 50(7): 597-600.
16.	Chen JM, Liu T, Gao S, et al. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: a prospective study in China. World J Gastroenterol, 2017, 23(46): 8235-8247.
17.	木婧熙, 张虎. 肠道超声学检查在克罗恩病中的应用及前景. 华西医学, 2019, 34(4): 448-453.
18.	Pai RK, Jairath V. What is the role of histopathology in the evaluation of disease activity in Crohn’s disease?. Best Pract Res Clin Gastroenterol, 2019, 38-39: 10601.
19.	Hart L, Bessissow T. Endoscopic scoring systems for the evaluation and monitoring of disease activity in Crohn’s disease. Best Pract Res Clin Gastroenterol, 2019, 38-39: 101616.
20.	Ma C, Battat R, Khanna R, et al. What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn’s disease activity?. Best Pract Res Clin Gastroenterol, 2019, 38-39: 101602.
21.	Romagnoni A, Jégou S, Van Steen K, et al. Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data. Sci Rep, 2019, 9(1): 10351.
22.	Uniken Venema WT, Voskuil MD, Vila AV, et al. Single-cell RNA sequencing of blood and ileal T cells from patients with Crohn’s disease reveals tissue-specific characteristics and drug targets. Gastroenterology, 2019, 156(3): 812-815.
23.	欧阳钦, 彭清海, 张萃. 炎症性肠病多学科协作诊治团队的建设与发展. 内科急危重症杂志, 2015, 21(1): 1-3.
24.	杨建波, 龚剑峰, 李毅, 等. 术前 CT 小肠造影预测克罗恩病与术中探查结果的一致性分析. 中华胃肠外科杂志, 2017(5): 555-559.
25.	Scoville EA, Schwartz DA. Endoscopy in inflammatory bowel disease: advances in disease management. Gastrointest Endosc, 2017, 86(6): 952-961.
26.	Takenaka K, Ohtsuka K, Kitazume Y, et al. Utility of magnetic resonance enterography for small bowel endoscopic healing in patients with Crohn’s disease. Am J Gastroenterol, 2018, 113(2): 283-294.
27.	Dulai PS, Peyrin-Biroulet L, Danese S, et al. Approaches to integrating biomarkers into clinical trials and care pathways as targets for treatment of inflammatory bowel diseases. Gastroenterology, 2019, 157(4): 1032-1043.
28.	Bettenworth D, Bokemeyer A, Baker M, et al. Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut, 2019, 68(6): 1115-1126.

1. 中华医学会消化病学分会炎症性肠病学组. 炎症性肠病诊断与治疗的共识意见 (2012 年·广州). 胃肠病学, 2012, 17(12): 763-781.
2. Torres J, Mehandru S, Colombel JF, et al. Crohn’s disease. Lancet, 2017, 389(10080): 1741-1755.
3. Nishida A, Inoue R, Inatomi O, et al. Gut microbiota in the pathogenesis of inflammatory bowel disease. Clin J Gastroenterol, 2018, 11(1): 1-10.
4. Ramos GP, Papadakis KA. Mechanisms of disease: inflammatory bowel diseases. Mayo Clin Proc, 2019, 94(1): 155-165.
5. Thia KT, Sandborn WJ, Harmsen WS, et al. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology, 2010, 139(4): 1147-1155.
6. Lee DW, Koo JS, Choe JW, et al. Diagnostic delay in inflammatory bowel disease increases the risk of intestinal surgery. World J Gastroenterol, 2017, 23(35): 6474-6481.
7. Coward S, Clement F, Benchimol EI, et al. Past and future burden of inflammatory bowel diseases based on modeling of population-based data. Gastroenterology, 2019, 156(5): 1345-1353.
8. Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet, 2018, 390(1114): 2769-2778.
9. Wang YF, Ouyang Q, Hu RW. Progression of inflammatory bowel disease in China. J Dig Dis, 2010, 11(2): 76-82.
10. Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn’s and Colitis Epidemiology Study. Gastroenterology, 2013, 145(1): 158-165.
11. 钱家鸣, 杨红. 中国炎症性肠病研究的历史回顾、现状和展望. 中国实用内科杂志, 2015, 35(9): 727-730.
12. Kaplan GG, Ng SC. Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China. Lancet Gastroenterol Hepatol, 2016, 1(4): 307-316.
13. APDW 2004 Chinese IBD Working Group. Retrospective analysis of 515 cases of Crohn’s disease hospitalization in China: nationwide study from 1990 to 2003. J Gastroenterol Hepatol, 2006, 21(6): 1009-1015.
14. Chen X, Yang K, Xu Y, et al. Top-100 highest-cited original articles in inflammatory bowel disease: a bibliometric analysis. Medicine, 2019, 98(20): e15718.
15. 郑家驹, 史肖华, 竺霞霜, 等. 我国克罗恩病不同年代发病率及患病率的比较. 中华内科杂志, 2011, 50(7): 597-600.
16. Chen JM, Liu T, Gao S, et al. Efficacy of noninvasive evaluations in monitoring inflammatory bowel disease activity: a prospective study in China. World J Gastroenterol, 2017, 23(46): 8235-8247.
17. 木婧熙, 张虎. 肠道超声学检查在克罗恩病中的应用及前景. 华西医学, 2019, 34(4): 448-453.
18. Pai RK, Jairath V. What is the role of histopathology in the evaluation of disease activity in Crohn’s disease?. Best Pract Res Clin Gastroenterol, 2019, 38-39: 10601.
19. Hart L, Bessissow T. Endoscopic scoring systems for the evaluation and monitoring of disease activity in Crohn’s disease. Best Pract Res Clin Gastroenterol, 2019, 38-39: 101616.
20. Ma C, Battat R, Khanna R, et al. What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn’s disease activity?. Best Pract Res Clin Gastroenterol, 2019, 38-39: 101602.
21. Romagnoni A, Jégou S, Van Steen K, et al. Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data. Sci Rep, 2019, 9(1): 10351.
22. Uniken Venema WT, Voskuil MD, Vila AV, et al. Single-cell RNA sequencing of blood and ileal T cells from patients with Crohn’s disease reveals tissue-specific characteristics and drug targets. Gastroenterology, 2019, 156(3): 812-815.
23. 欧阳钦, 彭清海, 张萃. 炎症性肠病多学科协作诊治团队的建设与发展. 内科急危重症杂志, 2015, 21(1): 1-3.
24. 杨建波, 龚剑峰, 李毅, 等. 术前 CT 小肠造影预测克罗恩病与术中探查结果的一致性分析. 中华胃肠外科杂志, 2017(5): 555-559.
25. Scoville EA, Schwartz DA. Endoscopy in inflammatory bowel disease: advances in disease management. Gastrointest Endosc, 2017, 86(6): 952-961.
26. Takenaka K, Ohtsuka K, Kitazume Y, et al. Utility of magnetic resonance enterography for small bowel endoscopic healing in patients with Crohn’s disease. Am J Gastroenterol, 2018, 113(2): 283-294.
27. Dulai PS, Peyrin-Biroulet L, Danese S, et al. Approaches to integrating biomarkers into clinical trials and care pathways as targets for treatment of inflammatory bowel diseases. Gastroenterology, 2019, 157(4): 1032-1043.
28. Bettenworth D, Bokemeyer A, Baker M, et al. Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut, 2019, 68(6): 1115-1126.

West China Medical Journal

Literature research of Crohn’s disease in Chinese journals from 1978 to 2017

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content